Physician profile
Nirali Patel
NPI 1346772027
$431.46
in general payments reported to CMS, 2019-2025
13 companies · $33.35 in 2025
The $33.35 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $41.58 · 2023: $263 · 2024: $94.03 · 2025: $33.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $80.85 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $63.47 | 2023-2024 | Flumist Quadrivalent, Farxiga, Airsupra |
| Alexion Pharmaceuticals, INC. | $42.84 | 2023 | Ultomiris |
| Glaxosmithkline, LLC. | $37.04 | 2023 | Benlysta, Pediarix, Rotarix |
| Eisai INC. | $35.84 | 2024 | |
| Braeburn INC. | $33.35 | 2025 | Brixadi |
| Astellas Pharma US INC | $26.75 | 2024 | Veozah |
| Janssen Biotech, INC. | $26.58 | 2022 | |
| Novo Nordisk INC | $22.58 | 2023 | |
| Indivior INC. | $21.70 | 2023 | Sublocade |
| Medtronic, INC. | $19.47 | 2023 | Minimed 770g |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Organon LLC | $5.99 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.